Incannex Healthcare Inc.

As of March 31, 2026, Incannex Healthcare Inc. carries a market capitalization of 41.05M, placing it among publicly traded companies globally. Its enterprise value stands at -33.29M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Incannex Healthcare Inc.'s next confirmed earnings release is scheduled for November 13, 2026.

As of March 31, 2026, Incannex Healthcare Inc. has 13.68M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Incannex Healthcare Inc. maintains a current ratio of 41.56, meaning it holds 41.6x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026.

As of the close on October 22, 2026, Incannex Healthcare Inc.'s stock has declined approximately 75.10% over the past 52 weeks. The 50-day moving average sits at 3.27, while the 200-day moving average is 4.47.

As of March 31, 2026, Incannex Healthcare Inc. holds 74.45M in cash and equivalents against 114,000.00 in total debt, resulting in a net debt position of -74.45M. Total book value stands at 75.23M, with working capital of 78.17M providing operational flexibility.

These figures cover the twelve months ended March 31, 2026.

Incannex Healthcare Inc.'s most recent stock split took place on February 27, 2026 with a 30:1 split ratio.